Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 95,600 shares at $198.08 ($18.9M) on 2024-09-12, disclosed to the SEC on 2024-09-13.
Scheduled sale ($18.9M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $195.16 | 3,957 | $772K | 4.1% |
| 2 | $195.16 | 3,957 | $772K | 4.1% |
| 3 | $195.43 | 8,497 | $1.7M | 8.8% |
| 4 | $195.43 | 8,497 | $1.7M | 8.8% |
| 5 | $195.72 | 6,458 | $1.3M | 6.7% |
| 6 | $195.72 | 6,458 |
| $1.3M |
| 6.7% |
| 7 | $196.07 | 2,727 | $535K | 2.8% |
| 8 | $196.07 | 2,727 | $535K | 2.8% |
| 9 | $197.04 | 1,696 | $334K | 1.8% |
| 10 | $197.04 | 1,696 | $334K | 1.8% |
| 11 | $197.55 | 1,385 | $274K | 1.4% |
| 12 | $197.55 | 1,385 | $274K | 1.4% |
| 13 | $198.08 | 2,086 | $413K | 2.2% |
| 14 | $198.08 | 2,086 | $413K | 2.2% |
| 15 | $198.43 | 3,392 | $673K | 3.6% |
| 16 | $198.43 | 3,392 | $673K | 3.6% |
| 17 | $198.93 | 4,008 | $797K | 4.2% |
| 18 | $198.93 | 4,008 | $797K | 4.2% |
| 19 | $199.22 | 2,945 | $587K | 3.1% |
| 20 | $199.22 | 2,945 | $587K | 3.1% |
| 21 | $200.15 | 3,600 | $721K | 3.8% |
| 22 | $200.41 | 4,159 | $834K | 4.4% |
| 23 | $200.41 | 4,159 | $834K | 4.4% |
| 24 | $200.98 | 2,395 | $481K | 2.5% |
| 25 | $200.98 | 2,395 | $481K | 2.5% |
| 26 | $201.52 | 1,895 | $382K | 2.0% |
| 27 | $201.52 | 1,895 | $382K | 2.0% |
| 28 | $201.81 | 800 | $161K | 0.9% |
| Total | $197.64 avg | 95,600 | $18.9M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |